Promising Results for Dupilumab in Treatment of Moderate to

New data on dupilumab demonstrate the drug’s potential usefulness in treating type 2 inflammation, a role central to respiratory diseases, including chronic obstructive pulmonary disease (COPD).

Related Keywords

Milan , Lombardia , Italy , Suryap Bhatt , , European Respiratory Society , International Congress , Critical Care , Copd , Dupilumab , Others ,